dihydroergocryptine has been researched along with Fibrocystic Breast Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Huerta, E; Garibay-Valencia, M; Mirabent-González, F | 1 |
| Castillo, E; Garibay, M; Mirabent, F | 1 |
2 trial(s) available for dihydroergocryptine and Fibrocystic Breast Disease
| Article | Year |
|---|---|
[Clinical comparision of alpha dihydroergocryptine against cabergoline in the treatment of the fibrocystic mastopathy].
Topics: Adolescent; Adult; Cabergoline; Dihydroergocryptine; Ergolines; Female; Fibrocystic Breast Disease; Galactorrhea; Gastrointestinal Diseases; Headache; Humans; Mastodynia; Middle Aged; Prolactin; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
[Effect of alpha dihydroergocryptine in patients with fibrocystic breast disease].
Topics: Adult; Dihydroergocryptine; Double-Blind Method; Female; Fibrocystic Breast Disease; Humans; Middle Aged; Prospective Studies | 2006 |